SHEFFIELD, England, February 1, 2021 / PRNewswire / – Rinri Therapeutics, a biotechnology firm creating a brand new cell-based remedy to revive listening to, as we speak pronounces the appointment of Nick Higgins as chairman of the board. He takes over from Dr. Erica Whittaker who has served as president since Rinri Therapeutics was created.
Nick’s profession spans greater than 35 years within the life sciences business throughout which he gained in depth data of the UK and US markets in each the private and non-private sectors. Nick was the previous chief government officer (CEO) of Intercytex Group plc, an organization centered on the event and manufacture of cell remedy merchandise that was subsequently bought via a collection of asset gross sales. He additionally served as Industrial Director for Acambis, a publicly traded UK firm centered on vaccines and novel biologics with important US operations (later bought to Sanofi), in addition to Company Growth Director for Consort Medical plc, a market capitalization of £ 500 million. UK-listed firm that has been acquired by Recipharm Group in 2020.
Nick at present serves on the Board of Administrators of Lizard BioConsulting (which he based), Avvinity Therapeutics (President), and Cell & Gene Remedy Catapult (Vice President).
Dr. Chandler, CEO of Rinri Therapeutics, stated: “I’m more than happy to welcome Nick as our new president. Nick will present useful info and steerage for the event of Rinri, bringing his in depth expertise in worldwide company growth together with private and non-private fundraising. Particularly, his time as CEO of cell remedy firm Intercytex gives a transparent parallel to Rinri as we proceed to develop our pioneering stem cell remedy. to reverse sensorineural listening to loss (SNHL) by repairing broken cytoarchitecture within the interior ear.“
Nick Higgins stated: “I’m delighted to hitch Rinri Therapeutics, an organization on the forefront of innovation within the remedy of listening to loss, at a time when the regenerative medication business is rising so quickly. I’ve been impressed by the standard of the science and administration group and sit up for serving to notice the potential of this world main know-how to enhance the lives of sufferers.. “
Nick Higgins joins the members of the instructor council Marcelo rivolta, Founder and Professor of Sensory Stem Cell Biology on the College of Sheffield; Dr Erica Whittaker, Director of UCB Ventures; Frank Kalkbrenner, International Director of BIVF; Dr. Claire Brown, Director of Buyers at BioCity; Ross McMaster, Finance Supervisor at SUEL (College of Sheffield’s Danger arm) and non-executive director Dr. Natalie Mount, CEO of Adaptate Biotherapeutics.
Photograph out there upon request
About Rinri Therapeutics
Rinri Therapeutics is a personal biotechnology firm that develops superior stem cell-based therapies to revive listening to. The corporate’s pioneering know-how seeks to reverse sensorineural listening to loss (SNHL) by repairing broken cytoarchitecture within the interior ear. It’s estimated that SNHL impacts 64 million sufferers within the US and 34 million in Europe. There are at present no drug remedy choices for sufferers with SNHL.
Rinri, is supported by the Boehringer Ingelheim Enterprise Fund (BIVF), UCB Ventures, BioCity and the College of Sheffield. Rinri was based in late 2018 and relies in Sheffield, UK.
For extra info, go to: www.rinri-therapeutics.com
Contacts:
Rinri Therapeutics
Dr Simon Chandler, CEO
admin@rinri-therapeutics.com
Citigate Dewe Rogerson
Sylvie Berrebi, Frazer Corridor
rinri@citigatedewerogerson.com
T: +44 (zero) 20 7638 9571
See unique content material: http: //www.prnewswire.com/news-releases/rinri-therapeutics-appoints-experienced-life-science-executive-nick-higgins-as-chairman-301218679.html
SOURCE Rinri Therapeutics
